B-Cell Scientist Wins National Grid Award
Joseph R. Tumang, PhD, was awarded this year’s National Grid Award for his work in unraveling B-lymphocyte development and B cell lymphoma. Dr. Tumang is an expert in immunology. He has identified changes in the programming of genes that trigger lymphoma. Understanding this process can ultimately help in the development of targeted medicines to treat this common cancer of the lymphatic system.
In a laboratory model of lymphoma, Dr. Tumang and colleagues have investigated how a molecule called BRD2 literally opens up the chromatin structure of the genome and allows for lots of genes to get activated, which then triggers cells to enter abnormal cell cycle division. He has identified processes that could help in determining why some patients are resistant to a particular lymphoma treatment and others are not. In addition to his work in lymphoma, Dr. Tumang also studies B1 lymphocytes which are implicated in many autoimmune diseases.
The National Grid fellowship will provide funding to further Dr. Tumang’s research.
Dr. Tumang works in the Feinstein’s Center for Oncology and Cell Biology, which is headed by Thomas L. Rothstein, MD, PhD. They are among hundreds of scientists at the institute commited to translational research – carrying out studies that will translate quickly into diagnostics or therapeutics that will alter the practice of medicine. The Feinstein Institute is part of the North Shore-LIJ Health System. Dr. Tumang will receive his award tonight, July 16th, during the Feinstein’s annual benefit concert featuring singer Diana Ross. The concert will be held at Planting Fields Aboretum.
National Grid is an international electricity and gas company that recently acquired KeySpan. The company is now the second largest U.S. electricity and natural gas provider that supplies electricity and contract services to the Long Island Power Authority.
Media Contact: Jamie Talan 516-562-1232/631-682-8781